Benjamin Drew Davies - 21 Jul 2022 Form 4 Insider Report for NATUS MEDICAL INC

Role
Executive VP and CFO
Signature
/s/ DOUGLAS BALOG by POWER OF ATTORNEY
Issuer symbol
N/A
Transactions as of
21 Jul 2022
Net transactions value
-$6,091,841
Form type
4
Filing time
21 Jul 2022, 17:10:00 UTC
Previous filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTUS Common Stock, $0.001 par value per share Award $0 +106,034 +140% $0.000000 181,846 21 Jul 2022 Direct F1
transaction NTUS Common Stock, $0.001 par value per share Disposed to Issuer $6,091,841 -181,846 -100% $33.50 0 21 Jul 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Benjamin Drew Davies is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock subject to performance-based stock unit awards that vested and were settled as a result of the merger ("Merger") pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc. ("Parent"), Prince Mergerco Inc, and Issuer ("Merger Agreement").
F2 Disposed of as a result of the Merger.
F3 Each share of Commons Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding.